DrugPatentWatch Database Preview

Therapeuticsmd Inc Company Profile

« Back to Dashboard

What is the competitive landscape for THERAPEUTICSMD INC, and what generic alternatives to THERAPEUTICSMD INC drugs are available?

THERAPEUTICSMD INC has three approved drugs.

There are thirteen US patents protecting THERAPEUTICSMD INC drugs.

There are ninety-two patent family members on THERAPEUTICSMD INC drugs in twelve countries and thirty supplementary protection certificates in twelve countries.

Summary for Therapeuticsmd Inc

International Patents:	92
US Patents:	13
Tradenames:	3
Ingredients:	3
NDAs:	3

Drugs and US Patents for Therapeuticsmd Inc

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Therapeuticsmd Inc	IMVEXXY	estradiol	INSERT;VAGINAL	208564-001	May 29, 2018		RX	Yes	No	9,289,382		Y
Therapeuticsmd Inc	IMVEXXY	estradiol	INSERT;VAGINAL	208564-002	May 29, 2018		RX	Yes	Yes	9,180,091		Y
Therapeuticsmd Inc	BIJUVA	estradiol; progesterone	CAPSULE;ORAL	210132-001	Oct 28, 2018		RX	Yes	Yes	8,993,549		Y
Therapeuticsmd Inc	IMVEXXY	estradiol	INSERT;VAGINAL	208564-002	May 29, 2018		RX	Yes	Yes	9,289,382		Y
Therapeuticsmd Inc	BIJUVA	estradiol; progesterone	CAPSULE;ORAL	210132-001	Oct 28, 2018		RX	Yes	Yes
Therapeuticsmd Inc	BIJUVA	estradiol; progesterone	CAPSULE;ORAL	210132-001	Oct 28, 2018		RX	Yes	Yes	9,114,145

International Patents for Therapeuticsmd Inc Drugs

Country	Patent Number	Estimated Expiration
Canada	2876964
World Intellectual Property Organization (WIPO)	2013112947
Japan	6342389
Japan	2015520236
Brazil	112014031837
European Patent Office	2782584

Supplementary Protection Certificates for Therapeuticsmd Inc Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1453521	39/2015	Austria		PRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211
0770388	SPC/GB09/026	United Kingdom		PRODUCT NAME: ESTRADIOL AND COMBINATIONS OF ESTRADIOL AND DIENOGEST, PREFERABLY ESTRADIOL VALERATE AND COMBINATIONS OF ESTRADIOL VALERATE AND DIENOGEST; REGISTERED: BE BE 327792 20081103; UK PL 00010/0576-0001 20081208
0770388	2009/012	Ireland		PRODUCT NAME: QLAIRA-ESTRADIOL VALERATE/DIENOGEST; NAT REGISTRATION NO/DATE: PA1410/58/1 20090109; FIRST REGISTRATION NO/DATE: BE327792 20081103
1380301	CA 2009 00017	Denmark		PRODUCT NAME: ETHINYLESTRADIOL (SOM BETADEXCLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 42417 (DK) 20080619; FIRST REG. NO/DATE: NL 33842 20070629
0402407	97C0005	Belgium		PRODUCT NAME: ESTRADIOL HEMIHYDRAAT; NAT. REGISTRATION NO/DATE: 298 IS 190 F 15 19960806; FIRST REGISTRATION: GB PL/0053/0241 19950711
1453521	122015000093	Germany		PRODUCT NAME: LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 87675.00.00 20150720; FIRST REGISTRATION: SLOWAKEI 17/0017/15-S 20150129

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Theragen
• Therapeuticsmd Inc
• Theratechnologies